Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy
Open Access
- 1 November 1993
- Vol. 72 (9), 2782-2785
- https://doi.org/10.1002/1097-0142(19931101)72:9<2782::aid-cncr2820720941>3.0.co;2-h
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantationAmerican Journal Of Medicine, 1989
- The diagnosis and treatment of posttransplant lymphoproliferative disordersCurrent Problems in Surgery, 1988
- REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPYThe Lancet, 1984
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976